Ventiv wins Bayer work and promotes three

Share this article:
Ventiv Pharma Services promoted Brad Patten to vice president of marketing and corporate development. He was the executive director of managed markets and business development. Julia Kelly was promoted to executive director, marketing. Andy Baldwin was promoted to senior director of network services.
The group also signed an agreement with Bayer's Diabetes care division, in which Ventiv will deploy a team of sales representatives to promote Bayer's complete range of Ascensia diabetes care products and services to retail pharmacists, strengthening Ventiv's service offering in this product category.
Terrell Herring, president and chief operating officer of Ventiv Pharma Services, said, "We have worked with Bayer over the past several years, and are very pleased to be able to provide our services to another Bayer HealthCare division. This decision underscores Bayer's continued confidence in Ventiv's ability to deliver positive results with their diagnostic product line."
"Pharmacists play a pivotal role in the lives of people with diabetes, and often are a person's most local or most trusted source of health information," said David Argento, director, national accounts for Bayer HealthCare's Diabetes care division. "By teaming with Ventiv, Bayer believes it can achieve one of its primary goals of supporting these health professionals in a way that has a meaningful impact on the lives of their patients."
Share this article:

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.